MCDERMOTT WILL & SCHULTE LLP
MCDERMOTT WILL & SCHULTE LLP filed a Q2 report for SURESCRIPTS on July 9, 2026, reporting $30,000 in lobbying income.
Lobbying for SURESCRIPTS · Health IT Company
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.